| Ticker Details |
|
Genprex, Inc.
|
| IPO Date: |
March 29, 2018 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$4.04M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.13 | 5.29%
|
| Avg Daily Range (30 D): |
$0.15 | 6.36%
|
| Avg Daily Range (90 D): |
$0.27 | 7.87%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.08M |
| Avg Daily Volume (30 D): |
1.51M |
| Avg Daily Volume (90 D): |
1.02M |
| Trade Size |
| Avg Trade Size (Sh.): |
16 |
| Avg Trade Size (Sh.) (30 D): |
195 |
| Avg Trade Size (Sh.) (90 D): |
48 |
| Institutional Trades |
| Total Institutional Trades: |
29 |
| Avg Institutional Trade: |
$1.57M |
| Avg Institutional Trade (30 D): |
$1.18M |
| Avg Institutional Trade (90 D): |
$1.18M |
| Avg Institutional Trade Volume: |
M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.5M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
.48K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$316.58
|
$-5
|
$-.17
|
|
Diluted EPS
|
|
|
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-16.77M
|
$-3.8M
|
$-4.67M
|
|
Operating Income / Loss
|
$-16.33M
|
$-3.35M
|
$-4.68M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$.11M
|
$M
|
$M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Oct 21, 2025
|
1:50
|
|
Feb 02, 2024
|
1:40
|
|
|
|